Surv.m-CRA-2-G

N/A

Report date: 2025/12/10 09:31:57

Base Information

Drug NameSurv.m-CRA-2-G

Drug Alias NameSurv.m-CRA-2-G

ClassificationBiologics > Oncolytic virus

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSurv BioPharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesSurv BioPharma Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A